End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.742 USD | -7.52% | -20.22% | -97.27% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 44
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 24 | 100.0 % | +454.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 24 | 100.0 % | +454.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Marc Beaudoin
COO | Chief Operating Officer | - | Jan. 24 |
Chief Tech/Sci/R&D Officer | 60 | 16-01-31 | |
Malek Chamoun
PRN | Corporate Officer/Principal | 39 | Jan. 24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 22-01-31 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Chief Tech/Sci/R&D Officer | 60 | 16-01-31 | |
Rabi Kiderchah
BRD | Director/Board Member | 51 | 21-10-30 |
Andrew Keller
BRD | Director/Board Member | 70 | 22-02-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,945,052 | 18,851,057 ( 99.50 %) | 0 | 99.50 % |
Stock B | 0 | 130,000 | 0 | 0 |
Company contact information
Sunshine Biopharma, Inc.
1177 Avenue of the Americas 5th Floor
10036, New York
+
http://www.sunshinebiopharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.27% | 751K | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SBFM Stock
- Company Sunshine Biopharma, Inc.